Towards a standard protocol for antimony intralesional infiltration technique for cutaneous leishmaniasis treatment

BACKGROUND: Despite its recognised toxicity, antimonial therapy continues to be the first-line drug for cutaneous leishmaniasis (CL) treatment. Intralesional administration of meglumine antimoniate (MA) represents an alternative that could reduce the systemic absorption of the drug and its side effe...

Descripción completa

Detalles Bibliográficos
Autores principales: da Silva, Rosiana Estéfane, Carvalho, Janaína de Pina, Ramalho, Dario Brock, Senna, Maria Camilo Ribeiro De, Moreira, Hugo Silva Assis, Rabello, Ana, Cota, Erika, Cota, Gláucia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Instituto Oswaldo Cruz, Ministério da Saúde 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5722261/
https://www.ncbi.nlm.nih.gov/pubmed/29236929
http://dx.doi.org/10.1590/0074-027601700125

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5722261/
https://www.ncbi.nlm.nih.gov/pubmed/29236929
http://dx.doi.org/10.1590/0074-027601700125

Ejemplares similares